DGS Capital Management LLC boosted its position in The Goldman Sachs Group, Inc. (NYSE:GS – Free Report) by 18.7% during the third quarter, Holdings Channel.com reports. The fund owned 877 shares of the investment management company’s stock after purchasing an additional 138 shares during the quarter. DGS Capital Management LLC’s holdings in The Goldman Sachs Group were worth $434,000 at the end of the most recent quarter.
Other institutional investors have also recently added to or reduced their stakes in the company. POM Investment Strategies LLC purchased a new stake in shares of The Goldman Sachs Group during the 2nd quarter worth about $26,000. Semmax Financial Advisors Inc. acquired a new position in The Goldman Sachs Group during the second quarter valued at approximately $26,000. Headlands Technologies LLC purchased a new stake in The Goldman Sachs Group during the second quarter worth approximately $27,000. Quest Partners LLC increased its position in shares of The Goldman Sachs Group by 6,300.0% in the second quarter. Quest Partners LLC now owns 64 shares of the investment management company’s stock worth $29,000 after acquiring an additional 63 shares in the last quarter. Finally, West Branch Capital LLC purchased a new position in shares of The Goldman Sachs Group in the 3rd quarter valued at $30,000. Hedge funds and other institutional investors own 71.21% of the company’s stock.
Insider Activity
In other The Goldman Sachs Group news, CEO David M. Solomon sold 6,550 shares of the company’s stock in a transaction that occurred on Friday, November 29th. The stock was sold at an average price of $610.91, for a total transaction of $4,001,460.50. Following the completion of the sale, the chief executive officer now owns 117,883 shares of the company’s stock, valued at $72,015,903.53. This represents a 5.26 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Brian J. Lee sold 2,000 shares of The Goldman Sachs Group stock in a transaction on Thursday, October 17th. The stock was sold at an average price of $530.90, for a total transaction of $1,061,800.00. Following the completion of the transaction, the insider now owns 10,095 shares in the company, valued at $5,359,435.50. This trade represents a 16.54 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 22,940 shares of company stock worth $13,717,979 in the last ninety days. Corporate insiders own 0.54% of the company’s stock.
The Goldman Sachs Group Stock Performance
The Goldman Sachs Group (NYSE:GS – Get Free Report) last issued its quarterly earnings results on Tuesday, October 15th. The investment management company reported $8.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.89 by $1.51. The company had revenue of $12.70 billion for the quarter, compared to analysts’ expectations of $11.77 billion. The Goldman Sachs Group had a return on equity of 11.39% and a net margin of 9.89%. The firm’s revenue for the quarter was up 7.4% on a year-over-year basis. During the same period last year, the firm earned $5.47 EPS. On average, sell-side analysts anticipate that The Goldman Sachs Group, Inc. will post 37.06 earnings per share for the current fiscal year.
The Goldman Sachs Group Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Monday, December 30th. Shareholders of record on Monday, December 2nd will be paid a dividend of $3.00 per share. This represents a $12.00 dividend on an annualized basis and a dividend yield of 2.05%. The ex-dividend date of this dividend is Monday, December 2nd. The Goldman Sachs Group’s dividend payout ratio (DPR) is currently 35.21%.
Analyst Upgrades and Downgrades
GS has been the subject of a number of research reports. Wells Fargo & Company upped their price target on shares of The Goldman Sachs Group from $600.00 to $680.00 and gave the stock an “overweight” rating in a research report on Friday, November 15th. Morgan Stanley increased their target price on The Goldman Sachs Group from $560.00 to $570.00 and gave the company an “overweight” rating in a research note on Wednesday, October 16th. Oppenheimer boosted their price target on The Goldman Sachs Group from $614.00 to $661.00 and gave the stock an “outperform” rating in a research report on Tuesday, November 5th. Keefe, Bruyette & Woods boosted their target price on shares of The Goldman Sachs Group from $570.00 to $686.00 and gave the stock an “outperform” rating in a research report on Tuesday, December 3rd. Finally, Barclays boosted their price objective on shares of The Goldman Sachs Group from $565.00 to $588.00 and gave the stock an “overweight” rating in a report on Wednesday, October 16th. Seven equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. Based on data from MarketBeat, The Goldman Sachs Group currently has a consensus rating of “Moderate Buy” and a consensus price target of $559.75.
Check Out Our Latest Report on The Goldman Sachs Group
About The Goldman Sachs Group
The Goldman Sachs Group, Inc, a financial institution, provides a range of financial services for corporations, financial institutions, governments, and individuals worldwide. It operates through Global Banking & Markets, Asset & Wealth Management, and Platform Solutions segments. The Global Banking & Markets segment provides financial advisory services, including strategic advisory assignments related to mergers and acquisitions, divestitures, corporate defense activities, restructurings, and spin-offs; and relationship lending, and acquisition financing, as well as secured lending, through structured credit and asset-backed lending and involved in financing under securities to resale agreements.
Read More
- Five stocks we like better than The Goldman Sachs Group
- How to Invest in Small Cap Stocks
- Texas Instruments: The Old-School Tech Titan Still Delivering
- What Investors Need to Know About Upcoming IPOs
- GRAIL: Biotech Stock Targeting $100B Cancer Market
- 3 REITs to Buy and Hold for the Long Term
- MarketBeat Week in Review – 12/9 – 12/13
Want to see what other hedge funds are holding GS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Goldman Sachs Group, Inc. (NYSE:GS – Free Report).
Receive News & Ratings for The Goldman Sachs Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Goldman Sachs Group and related companies with MarketBeat.com's FREE daily email newsletter.